. Author manuscript; available in PMC: 2016 Nov 20.

Published in final edited form as: Stat Med. 2015 Jun 21;34(26):3424–3443. doi: 10.1002/sim.6558

Table 4.

Linear regression for the effects of stage-1 treatments on the potential final outcome if their corresponding optimal stage-2 treatments had been received

	Estimate	SE	p-value
Intercept	1.248	0.1004	< 0.001
Age	−0.0109	0.0053	0.039
KA/VE vs. CVD	0.2366	0.1286	0.066
TEC vs. CVD	0.2757	0.1294	0.033
TEE vs. CVD	0.0475	0.1370	0.729